CN107969553A - A kind of preparation method of selenium nano particle microlayer polymeric composite gel - Google Patents
A kind of preparation method of selenium nano particle microlayer polymeric composite gel Download PDFInfo
- Publication number
- CN107969553A CN107969553A CN201711034367.5A CN201711034367A CN107969553A CN 107969553 A CN107969553 A CN 107969553A CN 201711034367 A CN201711034367 A CN 201711034367A CN 107969553 A CN107969553 A CN 107969553A
- Authority
- CN
- China
- Prior art keywords
- selenium
- nano particle
- preparation
- selenium nano
- polymeric composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011669 selenium Substances 0.000 title claims abstract description 83
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 82
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 59
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 39
- 239000002131 composite material Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 17
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 5
- 230000008602 contraction Effects 0.000 claims abstract 2
- 230000035945 sensitivity Effects 0.000 claims abstract 2
- 229940091258 selenium supplement Drugs 0.000 claims description 76
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 11
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 10
- 150000003342 selenium Chemical class 0.000 claims description 10
- 239000012154 double-distilled water Substances 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 8
- 239000003638 chemical reducing agent Substances 0.000 claims description 8
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical group [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 8
- 239000006185 dispersion Substances 0.000 claims description 8
- 229960001471 sodium selenite Drugs 0.000 claims description 8
- 239000011781 sodium selenite Substances 0.000 claims description 8
- 235000015921 sodium selenite Nutrition 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 2
- 210000004051 gastric juice Anatomy 0.000 claims description 2
- 230000000968 intestinal effect Effects 0.000 claims description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 2
- 230000002787 reinforcement Effects 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 11
- 241001465754 Metazoa Species 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 4
- 230000001079 digestive effect Effects 0.000 abstract description 3
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 229920000642 polymer Polymers 0.000 description 18
- 210000000813 small intestine Anatomy 0.000 description 8
- 239000000499 gel Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 3
- 238000005054 agglomeration Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 239000003674 animal food additive Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000007665 chronic toxicity Effects 0.000 description 2
- 231100000160 chronic toxicity Toxicity 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229940082569 selenite Drugs 0.000 description 2
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 2
- -1 sodium selenite Chemical compound 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000025563 intercellular transport Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000001986 peyer's patch Anatomy 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003746 solid phase reaction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- LEAHFJQFYSDGGP-UHFFFAOYSA-K trisodium;dihydrogen phosphate;hydrogen phosphate Chemical compound [Na+].[Na+].[Na+].OP(O)([O-])=O.OP([O-])([O-])=O LEAHFJQFYSDGGP-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种硒纳米颗粒高分子复合微凝胶的制备方法,具体涉及一种硒纳米颗粒pH 敏感高分子复合微凝胶的制备方法,属于硒纳米颗粒复合材料技术领域。The invention relates to a preparation method of a selenium nanoparticle polymer composite microgel, in particular to a preparation method of a selenium nanoparticle pH-sensitive polymer composite microgel, and belongs to the technical field of selenium nanoparticle composite materials.
背景技术Background technique
硒是人和动物体内必不可少的的微量元素,它对免疫力的提高,对清除自由基、维持新陈代谢的平衡、延缓衰老起到了不可替代的作用,缺硒会导致一系列生理疾病的发生。用于动物和人的硒补充制剂可分为无机硒(主要是亚硒酸盐)和有机硒(包括酵母硒、氨基酸硒等)。亚硒酸盐毒性大,安全应用范围窄,过量的硒对动物和人体产生毒性;有机硒的生物学利用率较高,急性毒性小,是良好的补硒品种,但仍存在局限,如仍有一定的慢性毒性,在饲料中应用成本高等。Selenium is an essential trace element in humans and animals. It plays an irreplaceable role in improving immunity, scavenging free radicals, maintaining metabolic balance, and delaying aging. Selenium deficiency can lead to a series of physiological diseases. . Selenium supplements for animals and humans can be divided into inorganic selenium (mainly selenite) and organic selenium (including yeast selenium, amino acid selenium, etc.). Selenite is highly toxic and has a narrow range of safe applications. Excessive selenium is toxic to animals and humans. Organic selenium has a high biological availability and low acute toxicity. It is a good selenium supplement, but there are still limitations. It has certain chronic toxicity and high application cost in feed.
纳米硒是尺寸范围在纳米尺度的单质硒,具有较高的生物学活性,显著拓宽了硒的中毒剂量与有效剂量的范围。纳米硒的急性毒性和慢性毒性均低于亚硒酸钠和酵母硒,是安全的硒制品,在饲料添加剂中具有较高的潜在应用价值。纳米硒被人和动物摄入后,在消化道内的吸收方式与无机硒、有机硒均不同。纳米微粒在胃肠道的吸收机制尚未完全阐明,普遍认为纳米微粒可以完整地被吸收,其吸收途径可能包括:被肠道上皮细胞摄取至细胞内,通过细胞间转运吸收,经Peyer氏集合淋巴结摄取,且其吸收部位主要是在小肠。Nano-selenium is elemental selenium with a size range of nanoscale, which has high biological activity and significantly broadens the range of toxic dose and effective dose of selenium. The acute and chronic toxicity of nano-selenium is lower than that of sodium selenite and yeast selenium. It is a safe selenium product and has high potential application value in feed additives. After nano-selenium is ingested by humans and animals, its absorption method in the digestive tract is different from that of inorganic selenium and organic selenium. The absorption mechanism of nanoparticles in the gastrointestinal tract has not been fully elucidated. It is generally believed that nanoparticles can be absorbed intact. The absorption pathways may include: uptake into cells by intestinal epithelial cells, absorption through intercellular transport, and Peyer's patches. Ingestion, and its absorption site is mainly in the small intestine.
目前已报道了多种制备纳米硒的方法,以液相化学法最为常用,如表面活性剂法、微乳液法、蛋白质模板法、聚合物模板法以及固相反应等。张胜义等利用甲壳素模板法制备了纳米硒(CN 1264521C);夏枚生等利用多孔矿物材料模板法制备了负载型纳米硒(CN100389058C);谭国龙等利用在水溶液中形成高分子骨架的稳定剂制备了纳米硒(CN103420344B)许详等人用琼脂模板法制备了琼脂负载型纳米硒(CN103445000B)。A variety of methods for preparing nano-selenium have been reported, among which liquid-phase chemical methods are most commonly used, such as surfactant method, microemulsion method, protein template method, polymer template method, and solid-phase reaction. Zhang Shengyi et al. prepared nano-selenium (CN 1264521C) by chitin template method; Xia Meisheng et al. prepared loaded nano-selenium (CN100389058C) by using porous mineral material template method; Tan Guolong et al. prepared nano Selenium (CN103420344B) Xu Xiang and others prepared agar-loaded nano-selenium (CN103445000B) by using the agar template method.
这些工艺中使用的的纳米硒载体一般为聚糖类、蛋白质等高分子物质,以及多孔矿物材料等,仅仅考虑了纳米硒颗粒在制备过程中的生成和分散,而对纳米硒颗粒进入消化道内从载体上的分离释放并未进行考虑,这就可能导致负载的纳米硒的释放速度难以控制的问题。若释放速度过快则可能导致非晶态的硒纳米颗粒的团聚而失去活性,释放速度过慢可能导致被排出体外而不能被动物利用。The nano-selenium carriers used in these processes are generally polymer substances such as polysaccharides and proteins, and porous mineral materials. The separation and release from the carrier is not considered, which may lead to the problem that the release rate of the loaded nano-selenium is difficult to control. If the release rate is too fast, it may cause the agglomeration of amorphous selenium nanoparticles and lose its activity, and if the release rate is too slow, it may be excreted from the body and cannot be used by animals.
纳米硒的生产成本和价格显著高于亚硒酸钠等无机硒,限制了其作为饲料添加剂的应用,因此,为提高纳米硒作为饲料添加剂的利用效率,应选择适合的纳米硒载体,以使其充分适应动物消化道内环境。The production cost and price of nano-selenium are significantly higher than inorganic selenium such as sodium selenite, which limits its application as a feed additive. Therefore, in order to improve the utilization efficiency of nano-selenium as a feed additive, suitable nano-selenium carriers should be selected so that It is fully adapted to the environment in the digestive tract of animals.
发明内容Contents of the invention
本发明所要解决的技术问题是为控制纳米硒在消化道内的释放,提供一种纳米硒pH敏感高分子复合微凝胶的制备方法。应用pH敏感凝胶作为硒纳米颗粒的模板和载体,使纳米硒在其主要吸收部位——pH较高的小肠内得以释放,以提高纳米硒的吸收利用率。The technical problem to be solved by the present invention is to provide a preparation method of nano-selenium pH-sensitive polymer composite microgel in order to control the release of nano-selenium in the digestive tract. The pH-sensitive gel is used as the template and carrier of selenium nanoparticles, so that the nano-selenium can be released in the small intestine with high pH, which is the main absorption site, so as to improve the absorption and utilization rate of nano-selenium.
解决上述技术问题所采用的技术方案由下述步骤组成:The technical solution adopted to solve the above technical problems consists of the following steps:
(1)制备pH敏感高分子复合微凝胶;(1) Preparation of pH-sensitive polymer composite microgels;
(2)(2)将步骤(1)的pH敏感高分子复合微凝胶作为硒纳米颗粒合成的模板和载体,(2) (2) using the pH-sensitive polymer composite microgel of step (1) as a template and a carrier for the synthesis of selenium nanoparticles,
负载硒盐并同时用还原剂还原硒盐,制备得到硒纳米颗粒高分子复合微凝胶。The selenium salt is loaded and the selenium salt is reduced with a reducing agent at the same time, and the selenium nanoparticle polymer composite microgel is prepared.
具体包括以下步骤:Specifically include the following steps:
(1)制备pH敏感高分子微凝胶。将甲基丙烯酸甲酯、甲基丙烯酸、N,N-亚甲基双丙烯酰胺和氢氧化钠均匀分散于重蒸馏水中,其中甲基丙烯酸甲酯、甲基丙烯酸、N,N-亚甲基双丙烯酰胺、氢氧化钠和重蒸馏水的质量比1:0.5~1:0.05~0.2:0.1~0.5:5~15,在氮气保护和搅拌状态下,加入过硫酸铵,过硫酸铵与甲基丙烯酸甲酯的质量比为1:0.1~0.:3,在40℃条件下恒温反应24h,反应产物经无水乙醇洗涤、离心分离、冷冻干燥,得到pH敏感聚甲基丙烯酸微凝胶;该微凝胶在胃液环境(pH<2)时处于收缩状态,在肠液(pH在6.5-7.5范围内)中溶胀;(1) Preparation of pH-sensitive polymer microgels. Disperse methyl methacrylate, methacrylic acid, N,N-methylenebisacrylamide and sodium hydroxide evenly in double distilled water, in which methyl methacrylate, methacrylic acid, N,N-methylene The mass ratio of bisacrylamide, sodium hydroxide and double distilled water is 1:0.5~1:0.05~0.2:0.1~0.5:5~15. Under nitrogen protection and stirring, add ammonium persulfate, ammonium persulfate and methyl The mass ratio of methyl acrylate is 1:0.1~0.:3, and it is reacted at a constant temperature at 40°C for 24 hours. The reaction product is washed with absolute ethanol, centrifuged, and freeze-dried to obtain pH-sensitive polymethacrylic acid microgel; The microgel is in a contracted state in the gastric juice environment (pH<2), and swells in the intestinal juice (pH in the range of 6.5-7.5);
(2)制备硒纳米颗粒复合高分子微凝胶。将高分子微凝胶均匀分散于二次蒸馏水中,配制成 0.5~1.0g/L的微凝胶分散液,向微凝胶分散液中加入硒盐,使其浓度达到0.4~2.0mmol/L,在搅拌状态下加入还原剂,还原剂与硒盐摩尔比为1:0.4~0.5,加入完毕后调节溶液pH至3以下,析出沉淀,即得到硒纳米颗粒复合高分子凝胶。(2) Preparation of selenium nanoparticles composite polymer microgel. Disperse the polymer microgel evenly in double distilled water to prepare a 0.5-1.0g/L microgel dispersion, add selenium salt to the microgel dispersion to make the concentration reach 0.4-2.0mmol/L , adding a reducing agent under stirring, the molar ratio of the reducing agent to the selenium salt is 1:0.4-0.5, after the addition is completed, the pH of the solution is adjusted to below 3, and precipitation is precipitated to obtain a composite polymer gel of selenium nanoparticles.
本发明所述的还原剂,其成分为L-抗坏血酸、硫代硫酸钠、亚硫酸氢钠的一种或几种的组合。The reducing agent of the present invention is composed of one or more combinations of L-ascorbic acid, sodium thiosulfate and sodium bisulfite.
本发明所述的硒盐,其成分为亚硒酸钠。The selenium salt of the present invention has a component of sodium selenite.
与现有纳米硒制备工艺相比,本工艺采用了新型的pH敏感凝胶作为模板和纳米硒载体。与其它类型的模板相比,凝胶的三维网络结构能够控制生成的纳米颗粒的尺寸,在硒的合成过程中起到尺寸稳定的作用,有效控制了硒纳米颗粒的粒径,减少了硒纳米颗粒的团聚。Compared with the existing nano-selenium preparation process, this process uses a novel pH-sensitive gel as a template and a nano-selenium carrier. Compared with other types of templates, the three-dimensional network structure of the gel can control the size of the generated nanoparticles, and play a role in dimension stability during the synthesis of selenium, effectively controlling the particle size of the selenium nanoparticles and reducing the size of the selenium nanoparticles. agglomeration of particles.
此外,作为硒纳米颗粒的载体,凝胶对于环境pH值的变化可以显示出显著的体积溶胀/ 收缩效应。进入消化道内后,凝胶负载的有效成分硒纳米颗粒在pH较低的胃内稳定,阻碍了纳米硒的释放。在pH较高的小肠等后消化道内溶胀,被包裹的纳米硒扩散到消化液中,同时小肠也是纳米颗粒的主要吸收部位,释放出的纳米硒被小肠迅速吸收利用。这就减少了纳米硒在消化液内的团聚,提高了硒的吸收利用率。In addition, as a carrier of Se nanoparticles, the gel can exhibit significant volume swelling/shrinking effects in response to changes in environmental pH. After entering the digestive tract, the gel-loaded active ingredient selenium nanoparticles are stable in the stomach where the pH is low, hindering the release of nano-selenium. It swells in the post-digestive tract such as the small intestine with a high pH, and the encapsulated nano-selenium diffuses into the digestive juice. At the same time, the small intestine is also the main absorption site of nanoparticles, and the released nano-selenium is quickly absorbed and utilized by the small intestine. This reduces the agglomeration of nano-selenium in the digestive juice and improves the absorption and utilization of selenium.
附图说明Description of drawings
图1为滤液中硒的含量附图。Fig. 1 is the accompanying drawing of the content of selenium in the filtrate.
具体实施方式Detailed ways
下面结合实施例,对本发明的具体实施方式作进一步详细描述。以下实施例用于说明本发明,但不用来限制本发明的范围。Below in conjunction with the examples, the specific implementation of the present invention will be further described in detail. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
实施例1Example 1
将甲基丙烯酸甲酯、甲基丙烯酸、甲基丙烯酸和氢氧化钠均匀分散于二次蒸馏水中,其中甲基丙烯酸甲酯、甲基丙烯酸、N,N-亚甲基双丙烯酰胺、氢氧化钠和重蒸馏水的质量比 1:0.5:0.1:0.2:10,在氮气保护和搅拌状态下,加入过硫酸铵,过硫酸铵与甲基丙烯酸甲酯的质量比为1:0.2,在40℃条件下恒温反应24h,反应产物经无水乙醇洗涤、离心分离、冷冻干燥,得到pH敏感聚甲基丙烯酸微凝胶。将微凝胶均匀分散于二次蒸馏水中,配制成0.5g/L 的微凝胶分散液,向微凝胶分散液中加入亚硒酸钠至1.0mmol/L,加入完毕后,在剧烈搅拌状态下加入5%L-抗坏血酸水溶液,其与亚硒酸钠摩尔比为1:0.45,反应保温1h,然后用1mol/L 盐酸调节溶液pH至2.5,析出硒纳米颗粒复合高分子微凝胶沉淀。Evenly disperse methyl methacrylate, methacrylic acid, methacrylic acid and sodium hydroxide in twice distilled water, wherein methyl methacrylate, methacrylic acid, N,N-methylenebisacrylamide, hydrogen The mass ratio of sodium and double-distilled water is 1:0.5:0.1:0.2:10. Under nitrogen protection and stirring, add ammonium persulfate. The mass ratio of ammonium persulfate to methyl methacrylate is 1:0.2. Under the conditions of constant temperature reaction for 24 hours, the reaction product was washed with absolute ethanol, centrifuged and freeze-dried to obtain pH-sensitive polymethacrylic acid microgel. Disperse the microgel evenly in double distilled water to prepare a 0.5g/L microgel dispersion, add sodium selenite to the microgel dispersion to 1.0mmol/L, after the addition is complete, stir vigorously Add 5% L-ascorbic acid aqueous solution under the state, the molar ratio of it and sodium selenite is 1:0.45, keep the reaction for 1h, then adjust the pH of the solution to 2.5 with 1mol/L hydrochloric acid, and precipitate the selenium nanoparticle composite polymer microgel precipitation .
实施例2Example 2
将甲基丙烯酸甲酯、甲基丙烯酸、甲基丙烯酸和氢氧化钠均匀分散于二次蒸馏水中,其中甲基丙烯酸甲酯、甲基丙烯酸、N,N-亚甲基双丙烯酰胺、氢氧化钠和重蒸馏水的质量比 1:1:0.2:0.3:15,在氮气保护和搅拌状态下,加入过硫酸铵,过硫酸铵与甲基丙烯酸甲酯的质量比为1:0.2,在40℃条件下恒温反应24h,反应产物经无水乙醇洗涤、离心分离、冷冻干燥,得到pH敏感聚甲基丙烯酸微凝胶。将微凝胶均匀分散于二次蒸馏水中,配制成1g/L的微凝胶分散液,向微凝胶分散液中加入亚硒酸钠至1.5mmol/L,加入完毕后,在剧烈搅拌状态下加入2%硫代硫酸钠水溶液,其与亚硒酸钠摩尔比为1:0.45,反应保温1h,然后用1mol/L盐酸调节溶液pH至2.0,得到硒纳米颗粒复合高分子微凝胶沉淀。Evenly disperse methyl methacrylate, methacrylic acid, methacrylic acid and sodium hydroxide in twice distilled water, wherein methyl methacrylate, methacrylic acid, N,N-methylenebisacrylamide, hydrogen The mass ratio of sodium to double-distilled water is 1:1:0.2:0.3:15. Under nitrogen protection and stirring, ammonium persulfate is added. The mass ratio of ammonium persulfate to methyl methacrylate is 1:0.2. Under the conditions of constant temperature reaction for 24 hours, the reaction product was washed with absolute ethanol, centrifuged and freeze-dried to obtain pH-sensitive polymethacrylic acid microgel. Disperse the microgel evenly in double distilled water to prepare a 1g/L microgel dispersion, add sodium selenite to the microgel dispersion to 1.5mmol/L, after the addition is complete, in a state of vigorous stirring Add 2% sodium thiosulfate aqueous solution, its molar ratio to sodium selenite is 1:0.45, keep the reaction for 1h, then adjust the pH of the solution to 2.0 with 1mol/L hydrochloric acid, and obtain the selenium nanoparticle composite polymer microgel precipitation .
实施例3Example 3
将获得的硒纳米颗粒复合高分子微凝胶沉淀进行离心,冷冻干燥,按GB/T13883-2008 的方法测定硒含量,其含硒为0.518%(质量百分比)。取实施例1制备的硒纳米颗粒高分子微凝胶1.0g。分别放置于10ml 0.1mol/L盐酸溶液(pH=2.0)和10ml磷酸二氢钠—磷酸氢二钠缓冲液(pH=7.0)中,分别静置1,2,3,4,5,6h,用200nm滤膜过滤,测定滤液中硒的含量,见附图1。The obtained selenium nanoparticle composite polymer microgel precipitate was centrifuged, freeze-dried, and the selenium content was determined according to the method of GB/T13883-2008, and the selenium content was 0.518% (mass percentage). Take 1.0 g of the selenium nanoparticle polymer microgel prepared in Example 1. Place them in 10ml 0.1mol/L hydrochloric acid solution (pH=2.0) and 10ml sodium dihydrogen phosphate-disodium hydrogen phosphate buffer solution (pH=7.0), let stand for 1, 2, 3, 4, 5, 6 hours respectively, Filter with 200nm filter membrane, measure the content of selenium in the filtrate, see accompanying drawing 1.
从图1可看出,硒纳米颗粒pH敏感高分子微凝胶在pH2.0的酸性环境(模拟胃环境)下硒含量变化缓慢,经过6h后释放率仅为62.9%,在pH7.0的中性环境(模拟小肠环境)中凝胶溶胀速度加快,1h后纳米硒颗粒已释放83.8%,表明硒纳米颗粒pH敏感高分子微凝胶具有较好的pH响应特性,能够保障足够的纳米硒颗粒到达吸收部位小肠,并且在小肠内迅速溶胀释放出硒纳米颗粒而被吸收,从而提高了利用率。It can be seen from Figure 1 that the selenium content of the pH-sensitive polymer microgel of selenium nanoparticles changes slowly in an acidic environment of pH 2.0 (simulated gastric environment), and the release rate is only 62.9% after 6 hours. In the neutral environment (simulated small intestine environment), the swelling speed of the gel is accelerated, and 83.8% of the nano-selenium particles have been released after 1 hour, indicating that the selenium nanoparticles pH-sensitive polymer microgel has good pH response characteristics and can ensure sufficient nano-selenium particles. The particles reach the small intestine where they are absorbed, and rapidly swell in the small intestine to release selenium nanoparticles for absorption, thereby improving the utilization rate.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711034367.5A CN107969553A (en) | 2017-10-30 | 2017-10-30 | A kind of preparation method of selenium nano particle microlayer polymeric composite gel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711034367.5A CN107969553A (en) | 2017-10-30 | 2017-10-30 | A kind of preparation method of selenium nano particle microlayer polymeric composite gel |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107969553A true CN107969553A (en) | 2018-05-01 |
Family
ID=62012791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711034367.5A Pending CN107969553A (en) | 2017-10-30 | 2017-10-30 | A kind of preparation method of selenium nano particle microlayer polymeric composite gel |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107969553A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4170685A (en) * | 1976-03-29 | 1979-10-09 | California Institute Of Technology | Polyvinyl pyridine microspheres |
CN1473648A (en) * | 2003-08-08 | 2004-02-11 | 陕西师范大学 | Preparation method of surface patterned sulfide polymer composite microspheres |
CN1973999A (en) * | 2006-12-08 | 2007-06-06 | 南京大学 | Mesoporous titania meterial containing selenium and its prepn process |
CN102245528A (en) * | 2008-12-15 | 2011-11-16 | 科学与工业研究委员会 | Self standing nanoparticle networks/scaffolds with controllable void dimensions |
CN103420344A (en) * | 2012-05-14 | 2013-12-04 | 武汉理工大学 | Preparation method for nano-selenium |
CN103752237A (en) * | 2014-01-10 | 2014-04-30 | 陕西师范大学 | Preparation method of pH sensitive microgel loaded nanogold |
CN104128136A (en) * | 2013-05-03 | 2014-11-05 | 中国科学院化学研究所 | Micro-nano gel particle, controllable preparation method and application thereof |
CN105218835A (en) * | 2015-09-25 | 2016-01-06 | 西北师范大学 | A kind of preparation of keratin based sensitive high-molecular gel and the application as pharmaceutical carrier |
-
2017
- 2017-10-30 CN CN201711034367.5A patent/CN107969553A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4170685A (en) * | 1976-03-29 | 1979-10-09 | California Institute Of Technology | Polyvinyl pyridine microspheres |
CN1473648A (en) * | 2003-08-08 | 2004-02-11 | 陕西师范大学 | Preparation method of surface patterned sulfide polymer composite microspheres |
CN1973999A (en) * | 2006-12-08 | 2007-06-06 | 南京大学 | Mesoporous titania meterial containing selenium and its prepn process |
CN102245528A (en) * | 2008-12-15 | 2011-11-16 | 科学与工业研究委员会 | Self standing nanoparticle networks/scaffolds with controllable void dimensions |
CN103420344A (en) * | 2012-05-14 | 2013-12-04 | 武汉理工大学 | Preparation method for nano-selenium |
CN104128136A (en) * | 2013-05-03 | 2014-11-05 | 中国科学院化学研究所 | Micro-nano gel particle, controllable preparation method and application thereof |
CN103752237A (en) * | 2014-01-10 | 2014-04-30 | 陕西师范大学 | Preparation method of pH sensitive microgel loaded nanogold |
CN105218835A (en) * | 2015-09-25 | 2016-01-06 | 西北师范大学 | A kind of preparation of keratin based sensitive high-molecular gel and the application as pharmaceutical carrier |
Non-Patent Citations (1)
Title |
---|
梁红莲: "硒及其硒化银-高分子复合微球的微凝胶模板法制备研究", 《中国优秀硕士学位论文全文数据库》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111317135A (en) | Method for embedding slow-release curcumin by polyphenol-modified zein nanoparticles | |
CN108653238A (en) | A kind of lignin-histidine medicine-carried nano particles and preparation method thereof with pH responses | |
Mokhtari et al. | Water compatible molecularly imprinted polymer for controlled release of riboflavin as drug delivery system | |
CN102161729A (en) | Preparation method of water-soluble polysaccharide/hydrophobic monomer formed nanoparticles | |
CN104627958B (en) | Modified Nano particle that a kind of stability strengthens and preparation method thereof | |
CN108676177A (en) | It is a kind of using nano-starch particle as the intelligent aqueous gel processing method of skeleton | |
CN111437385B (en) | Chitosan derivative nanoparticles and preparation method and application thereof | |
CN112999161A (en) | Preparation method of eucommia ulmoides geniposide acid composite nano-particles | |
CN103450364B (en) | Carboxymethyl starch with high substitution degree and composite aquogel, preparation method and application | |
CN103892165A (en) | Xanthophylls nano dispersion liquid with control release property as well as preparation method | |
CN108541866A (en) | A kind of cinnamic acid-sodium alginate-chitosan nanoparticle and preparation method thereof | |
AU2021106295A4 (en) | A hyaluronic acid-astaxanthin self-assembled nano system and the preparation method and its application | |
CN105963278A (en) | Preparation method of amycin controlled-release chitosan nano particles with pH/oxido-reduction dual response | |
CN112755980A (en) | Composite hydrogel, preparation method thereof and application thereof in adsorption treatment | |
CN105412924B (en) | Nano-particle of the photodynamic therapy containing sugar and preparation method thereof with blood stability and targeting | |
Wardhani et al. | Modification of glucomannan of Amorphophallus oncophyllus as an excipient for iron encapsulation performed using the gelation method | |
CN109172541B (en) | A kind of preparation method of stable nano curdlan iron | |
CN107969553A (en) | A kind of preparation method of selenium nano particle microlayer polymeric composite gel | |
CN117659226A (en) | Chitosan containing sulfhydryl group and preparation method and application thereof | |
CN103694479B (en) | Polymkeric substance, glucose-sensitive nanogel, glucose-sensitive medicament-carried nano gel and preparation method thereof | |
RU2557992C1 (en) | Antioxidant agent of nanostructured selenium with hepatoprotective effect and methods for producing and using it | |
CN102120823B (en) | The synthesis of water solublity zein and the utilization in pharmaceutical preparation | |
CN110934304A (en) | Loaded vitamin D3Preparation method of modified chitosan nanoparticles | |
CN100400580C (en) | A kind of polyelectrolyte polysaccharide nanoparticle and preparation method thereof | |
CN114702687B (en) | Preparation method and application of cyclodextrin MOF particle antibiotic substitute |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180501 |